Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Anti-SLAMF7 CAR T cells |
| Trade Name | |
| Synonyms | Autologous Anti-SLAMF7 CAR T-cells|SLAMF7 CAR-T cells |
| Drug Descriptions |
Anti-SLAMF7 CAR T cells are T-cells that express a chimeric antigen receptor derived from the SLAMF7 (CS1)-targeting antibody elotuzumab, which potentially results in anti-tumor activity against SLAMF7-expressing tumor cells (PMID: 29089311). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C161635 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Anti-SLAMF7 CAR T cells | Anti-SLAMF7 CAR T cells | 0 | 1 |
| Anti-SLAMF7 CAR T cells + Cyclophosphamide + Fludarabine | Anti-SLAMF7 CAR T cells Cyclophosphamide Fludarabine | 0 | 1 |